Goldman Sachs’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-179,235
Closed -$58.4M 6023
2024
Q1
$58.4M Buy
179,235
+33,780
+23% +$8.29M 0.01% 1066
2023
Q4
$27.7M Sell
145,455
-6,540
-4% -$1.24M 0.01% 1615
2023
Q3
$30.3M Sell
151,995
-48,605
-24% -$11.5M 0.01% 1450
2023
Q2
$57.3M Sell
200,600
-40,667
-17% -$11.3M 0.01% 1003
2023
Q1
$52.3M Sell
241,267
-64,531
-21% -$12.6M 0.01% 1046
2022
Q4
$62.9M Sell
305,798
-139,874
-31% -$35.4M 0.02% 989
2022
Q3
$124M Buy
445,672
+187,923
+73% +$47.8M 0.03% 581
2022
Q2
$49.3M Sell
257,749
-30,796
-11% -$5.44M 0.01% 1130
2022
Q1
$59.8M Buy
288,545
+45,542
+19% +$7.51M 0.01% 1138
2021
Q4
$43.3M Buy
243,003
+27,085
+13% +$5.34M 0.01% 1465
2021
Q3
$44.5M Buy
215,918
+9,503
+5% +$1.87M 0.01% 1361
2021
Q2
$39.2M Buy
206,415
+113,447
+122% +$18.6M 0.01% 1471
2021
Q1
$12.1M Sell
92,968
-90,716
-49% -$10.9M ﹤0.01% 2393
2020
Q4
$19.1M Sell
183,684
-17,007
-8% -$1.47M ﹤0.01% 1896
2020
Q3
$15.2M Sell
200,691
-9,847
-5% -$558K ﹤0.01% 1964
2020
Q2
$9.97M Buy
210,538
+177,916
+545% +$7.33M ﹤0.01% 2276
2020
Q1
$1.08M Buy
32,622
+11,740
+56% +$466K ﹤0.01% 3695
2019
Q4
$917K Sell
20,882
-31,555
-60% -$1.17M ﹤0.01% 4181
2019
Q3
$1.57M Buy
52,437
+2,019
+4% +$85.7K ﹤0.01% 3706
2019
Q2
$2.88M Sell
50,418
-75,646
-60% -$3.67M ﹤0.01% 3273
2019
Q1
$4.22M Buy
+126,064
New +$4.19M ﹤0.01% 3107

Other funds holding SWAV

Goldman Sachs's SWAV Position: Q2 2024 in Review

Goldman Sachs sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 179,235 shares — an estimated $58.4M sold.

Goldman Sachs first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $124M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Goldman Sachs reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Goldman Sachs sold 179,235 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $58.4M.
  • Goldman Sachs first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • Goldman Sachs's Shockwave Medical, Inc. Common Stock position peaked at $124M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Goldman Sachs's 13F filing for Q2 2024, filed 13 Aug 2024.